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Abstract
Introduction:	Morphological	correlates	of	nonpathological	déjà	vu	 (DV)	have	been	
identified	recently	within	the	human	brain.	Significantly	reduced	gray	matter	volume	
(GMV)	within	a	set	of	cortical	and	subcortical	regions	reported	in	subjects	experienc-
ing	DV	seems	to	mirror	the	distribution	of	GMV	reduction	in	mesial	temporal	lobe	
epilepsy	(MTLE)	patients	but	vary	in	terms	of	the	hippocampus.	Another	condition	
associated	with	hippocampal	GMV	reduction	and	DV	alike	disturbance	 in	memory	
processing	is	schizophrenia	(SCH).	Here,	we	tested	the	hypothesis	that	hippocampal	
involvement	in	nonpathological	DV	resembles	more	closely	the	pattern	of	GMV	de-
crease	observed	in	MTLE	compared	with	that	occurring	in	SCH.
Methods:	Using	automated	segmentation	of	the	MRI	data	we	compared	the	medians	
of	GMV	within	12	specific	hippocampal	subfields	in	healthy	individuals	that	do	(DV+;	
N	=	87)	and	do	not	report	déjà	vu	experience	(DV−;	N	=	26),	and	patients	with	MTLE	
(N	=	47)	and	SCH	(N	=	29).	By	Pearson	correlation,	we	then	evaluated	the	similarity	of	
MTLE	and	SCH	groups	 to	DV+	group	with	 respect	 to	 spatial	 distribution	of	GMV	
deviation	from	DV−	group.
Results:	Significant	GMV	decrease	was	found	in	MTLE	group	in	most	of	the	subfields.	
There	were	 just	 trends	 in	 the	 hippocampal	 GMV	 decrease	 found	 in	DV+	 or	 SCH	
groups.	Concerning	the	spatial	distribution	of	GMV	decrease,	we	revealed	statisti-
cally	 significant	 correlation	 for	 the	 left	 hippocampus	 for	 SCH	 vs	DV+.	Otherwise	
there was no statistically significant correlation.
Conclusions: Our findings reveal structural features of hippocampal involvement in 
nonpathological	DV,	MTLE,	and	SCH.	Despite	our	expectations,	the	pattern	of	GMV	
reduction	in	the	DV+	relative	to	the	DV−	group	does	not	resemble	the	pattern	ob-
served	in	MTLE	any	more	than	that	observed	in	SCH.	The	highly	similar	patterns	of	
the three clinical groups rather suggest an increased vulnerability of certain hip-
pocampal	subfields;	namely,	Cornu	Ammonis	(CA)4,	CA3,	dentate	gyrus	granular	cell	
layer	(GC-	DG),	hippocampal–amygdaloid	transition	area	(HATA)	and	subiculum.
K E Y W O R D S
deja	vu,	hippocampal	subfields,	hippocampal	vulnerability,	mesial	temporal	lobe	epilepsy,	
schizophrenia
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1  | INTRODUC TION
Déjà	 vu	 (DV)	 is	 a	 complex	 phenomenon	 of	 erroneous	 familiarity.	
When	experienced	by	up	to	76%	of	the	healthy	population	(Adachi	
et	al.,	 2003),	 DV	 is	 believed	 to	 reflect	 aberrant	 yet	 nonpathologi-
cal	 brain	 function	 among	 memory-	related	 neural	 systems	 (Shaw,	
Mareček,	&	Brázdil,	2015).	On	the	other	hand,	DV	experience	occurs	
also	 as	 a	manifestation	of	neurological	 diseases,	 such	 as	 temporal	
lobe	epilepsy	(as	a	type	of	aura;	 Illman,	Butler,	Souchay,	&	Moulin,	
2012),	 and	 in	 several	 psychiatric	 disorders,	 such	 as	 anxiety	or	de-
pression	(Richardson	&	Winokur,	1967).	While	different	in	frequency	
and	 duration,	DV	 appears	 to	 be	 qualitatively	 same	whether	 it	 oc-
curs	as	a	benign	nonpathological	event	or	in	the	context	of	epilepsy	
(Warren-	Gash	&	Zeman,	2014).
Recently,	morphological	correlates	of	nonpathological	DV	have	
been identified within the human brain using magnetic resonance 
imaging	(MRI,	Brázdil	et	al.,	2012;	Labate	et	al.,	2015).	Using	highly	
sensitive source- based morphometry to investigate a large cohort 
of	healthy	subjects,	significantly	reduced	gray	matter	volume	(GMV)	
was	revealed	within	bilateral	mesiotemporal	regions	(namely	hippo-
campi	and	parahippocampal	gyri),	insular	cortices,	superior	temporal	
sulci,	basal	ganglia	and	thalami	in	subjects	reporting	prior	experience	
of	DV	compared	to	those	reporting	no	such	experience.	Importantly,	
GMV	within	these	regions	correlated	inversely	with	the	frequency	of	
DV	experience	(Brázdil	et	al.,	2012).
This	finding	converges	closely	with	the	results	of	a	study	by	Shaw	
et	al.	(2015),	whereby	GMV	reductions	among	medial	temporal	lobe	
structures were found to covary more strongly in healthy individuals 
reporting	a	higher	frequency	of	DV	experience	(Shaw	et	al.,	2015).
More	direct	evidence	for	the	role	of	medial	temporal	lobes	in	DV	
experience	comes	from	the	electrophysiological	study	by	Bancaud,	
Brunet-	Bourgin,	Chauvel,	and	Halgren	(1994).	These	authors	applied	
intracerebral	 electrical	 stimulation	 to	 evoke	 DV	 in	 patients	 with	
temporal lobe epilepsy. They concluded that the hippocampus and 
amygdala	play	key	roles	 in	 the	genesis	of	DV	experience,	with	the	
temporal	neocortex	providing	a	secondary	but	important	contribu-
tion	(Bancaud	et	al.,	1994).
The hippocampal formation is a gray matter region essential 
in memory functions. It consists of anatomically and functionally 
distinct	subfields:	presubiculum,	parasubiculum,	subiculum,	Cornu	
Ammonis	(CA)1,	CA2,	CA3,	CA4,	granular	cell	layer	of	the	dentate	
gyrus	 (GC-	DG),	 fimbria,	 hippocampal–amygdaloid	 transition	 area	
(HATA),	hippocampal	molecular	layer	(molecular	layer	HP),	fissure	
and	tail.	Some	authors	include	also	entorhinal	cortex	which	serves	
as the main “interface” between the hippocampus and other parts 
of	 the	 brain	 (Andersen,	Morris,	 Amaral,	 Bliss,	 &	OKeefe,	 2006).	
The	 trisynaptic	 pathway	 from	 the	 entorhinal	 cortex,	 inducing	
serial	 excitatory	 transmission	 through	CA4,	GC-	DG,	 CA2-	3,	 and	
CA1,	and	leading	back	to	the	entorhinal	cortex	through	the	subic-
ulum,	is	then	considered	to	be	a	fundamental	network	involved	in	
learning	and	memory	(Tamminga,	Stan,	&	Wagner,	2010).
Aside	from	DV	phenomenon,	hippocampal	volume	is	decreased	
frequently	 in	 the	 setting	 of	 epilepsy.	 The	 set	 of	 brain	 regions	
distinguishing	 brain	 experiencing	DV	 (Brázdil	 et	al.,	 2012)	 remark-
ably	mirrored	 the	 distribution	 of	 GMV	 reduction	 in	 subjects	with	
mesial	 temporal	 lobe	 epilepsy	 (MTLE)	 with	 hippocampal	 sclerosis	
(HS)	 involving	hippocampal	and	parahippocampal	 regions,	entorhi-
nal	 and	 perirhinal	 cortices,	 amygdala,	 lateral	 temporal	 neocortex,	
thalamic	and	striatal	nuclei,	cingulate	gyrus,	 insula,	and	cerebellum	
(Brázdil	et	al.,	2009;	Keller	&	Roberts,	2008;	Labate	et	al.,	2015;	Pail,	
Brázdil,	Mareček,	&	Mikl,	2010).	 Interestingly	 the	pattern	of	GMV	
reduction	seems	to	be	distinctive	within	the	hippocampi	(Brázdil	&	
Zeman,	2013).
A	 significant	 reduction	 in	 hippocampal	 volume	 was	 also	
found	 in	 several	 mental	 disorders,	 such	 as	 in	 the	 case	 of	
schizophrenia,	 where	 both	 neurodevelopmental	 and	 degen-
erative processes are thought to contribute to the pattern of 
neuroanatomic	 changes	 (Haukvik	 et	al.,	 2015;	 Honea,	 Crow,	
Passingham,	&	Mackay,	2005;	Kühn	et	al.,	2012;	Mathew	et	al.,	
2014).	 Hippocampus	 is	 presumably	 a	 key	 structure	 in	 patho-
physiology	 of	 schizophrenia	 (Lodge	 &	 Grace,	 2011).	 Impaired	
hippocampal	 recruitment	 during	 the	 memory	 recall	 (Heckers	
et	al.,	 1998;	 Weiss	 et	al.,	 2003)	 combined	 with	 attribution	 of	
strong behavioral importance to stimuli that would be other-
wise	safely	ignored	(termed	“aberrant	salience”)	is	suggested	to	
potentially underlie delusional or hallucinatory states in schizo-
phrenia	 (Kapur,	 2003).	 Remarkably,	 this	 concept	 of	 providing	
irrelevant	 context	 to	 currently	 processed	 percepts/cognitions	
corresponds with one of the widely accepted theories consid-
ering mechanisms behind déjà vu. It is believed that aberrant 
memory processing leads to implicit familiarity of unrecognized 
stimuli	(Brown,	2003).
The aforementioned results of morphology studies in healthy 
individuals and electrophysiological investigations with epileptic pa-
tients point to the important role of the hippocampal formation in 
the	genesis	of	pathological	and	nonpathological	DV.
The	 question	 is	 whether	 the	 morphological	 correlate	 of	 non-
pathological	DV	 in	terms	of	hippocampal	subfields	converges	with	
this	one	of	MTLE	as	a	condition	with	corresponding	morphological	
correlate in various sites of the brain or with the schizophrenia which 
carries similar concept considering underlying mechanisms.
To	answer	 this	 inquiry	and	 to	define	 the	precise	 involvement	
of	 the	 hippocampus	 in	DV,	we	 used	 automated	 segmentation	 to	
assess	and	compare	GMV	across	the	hippocampal	subfields	in	four	
patient groups. The first group consisted of healthy individuals 
reporting	DV	experience	 regarded	 as	 nonpathological	 (DV+),	 the	
second	 group	 consisting	 of	 those	 reporting	 no	 such	 experience	
(DV−),	and	the	third	and	fourth	group	comprising	patients	suffer-
ing	from	MTLE	and	schizophrenia	(SCH)	(with	their	DV	considered	
as	pathological).
Based	on	reports	of	high	neuroanatomical	similarity	in	healthy	
individuals	 reporting	 nonpathological	 DV	 and	 MTLE	 patients	 in	
whom	 pathological	 DV	 occurs	 frequently,	 we	 hypothesized	 that	
patterns	 of	 GMV	 reduction	 across	 hippocampal	 subfields	 in	 the	
DV+	 group	 would	 resemble	 those	 measured	 in	 MTLE	 but	 dif-
fer	 from	 those	observed	 in	 the	 SCH	group	with	 a	more	 complex	
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pattern of clinical presentation and distinct underlying hippocam-
pal neuropathology.
2  | METHODS
2.1 | Subjects
Our sample comprised a total of 189 subjects participated in the 
study.
The	 MTLE	 group	 consisted	 of	 a	 left-	sided	 (L-	MTLE;	 N = 27; 
8M,	 19F;	 median	 age	=	40.2	years;	 range	=	17.7	 –	 54.6	years)	
and	 right-	sided	 subgroup	 (R-	MTLE;	 N	=	20;	 6M,	 14F;	 median	
age	=	38.2	years;	range	=	24.8	–	61.1	years).	For	the	L-	MTLE	sub-
group,	 the	median	 age	 at	 the	 time	 of	 disease	 onset	was	 3	years	
(range	1	–	35	years),	the	median	disease	duration	was	32.5	years	
(range	 6	 –	 54	years),	 and	 the	 median	 seizure	 frequency	 was	
4	 seizures	 per	month	 (range	 2	 –	 135	 seizures).	 For	 the	 R-	MTLE	
subgroup,	 the	median	 age	 at	 the	 time	 of	 the	 disease	 onset	was	
5.5	years	 (range	8	months	–	40	years),	 the	median	disease	dura-
tion	was	29.5	years	 (range	8	–	55	years),	and	 the	median	seizure	
frequency	was	4.75	seizures	per	month	(1	–	13).
At	the	time	of	testing,	the	subgroups	did	not	differ	significantly	
in	 age	 (p	=	.97,	T–test),	 gender	 (p = .48; T–test),	 disease	 duration	
(p	=	.60,	T–test)	or	seizure	 frequency	 (p	=	.40,	T–test).	There	was	
no significant variance between the subgroups in their positive 
history	of	febrile	convulsions	(seven	in	L-	MTLE	and	six	in	R-	MTLE;	
p	=	.74,	T–test).	Majority	of	the	subjects	had	a	history	of	complex	
partial	 seizures.	 Ten	 patients	 in	 the	 L-	MTLE	 subgroup	 and	 eight	
patients	 in	the	R-	MTLE	subgroup	also	presented	secondary	gen-
eralized	seizures.	One	patient	with	L-	MTLE	and	one	with	R-	MTLE	
had	simple	partial	seizures.	DV	in	the	context	of	aura	was	reported	
solely by one patient. The only statistically significant divergence 
between the subgroups was in the number of prescribed antiepi-
leptic	drugs	(number	of	types):	a	mean	of	2.3	medications	for	the	
L-	MTLE	subgroup,	and	a	mean	of	1.8	medications	for	R-	MTLE	sub-
group	(p	=	.03,	T-	test).	The	diagnosis	of	unilateral	MTLE	was	based	
on	a	consonance	of	history	data,	ictal	and	interictal	EEG	findings	
(long-	term	 semi-	invasive	 video-	EEG	 monitoring	 with	 sphenoidal	
electrodes),	ictal	semiology,	neuropsychology,	neuroimaging	find-
ings,	 and	 fulfillment	 of	 the	 diagnostic	 criteria	 for	MTLE	 accord-
ing	 to	 the	 International	 League	 Against	 Epilepsy	 (ILAE)	 criteria	
(Commission	 on	 Classification	 and	 Terminology	 of	 ILAE,	 1989).	
As	 another	 inclusion	 criteria	was	 set	 also	hippocampal	 sclerosis,	
which	 is	 a	 substrate	 characterizing	 classical	 TLE	 (Hogan,	 2001).	
Unilateral	 hippocampal	 sclerosis	 MRI	 evidence	 concordant	 with	
the	EEG	 lateralization	of	 the	epileptogenic	zone	was	 found	 in	all	
subjects. None of the subjects revealed any other structural brain 
lesions	on	MRI	scans,	and	none	had	undergone	previous	intracra-
nial	surgery.	All	subjects	had	been	seizure	free	for	24	hr	prior	to	
the MRI investigation.
The	 SCH	 group	 comprised	 of	 29	 subjects	 (23M,	 6F;	 median	
age	=	33	years;	range	=	19.3	–	45.1	years)	with	a	median	disease	du-
ration	of	4.5	years	(range	=	1	-	288	months).	The	symptom	severity	
in	these	patients	was	assessed	with	Positive	and	Negative	Syndrome	
Scale	(PANSS;	Kay,	Fiszbein,	&	Opler,	1987).	Patients	scored	a	me-
dian	 of	 14	 points	 (range	=	7	 –	 20	 points)	 on	 the	 positive	 scale,	 a	
median	score	of	21	points	(range	=	10	–	29	points)	on	the	negative	
scale,	and	a	median	of	38	points	(range	=	21	–	53	points)	on	the	gen-
eral	 psychopathology	 scale.	 The	 median	 of	 experienced	 episodes	
was	2	(range	=	1	-	8	episodes)	during	the	course	of	the	disease,	and	
all subjects were on stable antipsychotic medication with median of 
1	 (range	=	1-	2	drugs,	 all	 atypical	 antipsychotics).	None	of	 the	 sub-
jects reported history of epilepsy or signs of hippocampal sclerosis 
on MRI.
The	DV+	group	comprised	of	87	healthy	volunteers	(45M,	42F;	
median	age	=	24.1	years;	range	=	19.1	–	46.2	years)	with	no	personal	
or	 family	 history	 of	 epilepsy	 or	 schizophrenia.	 All	 subjects	 com-
pleted	the	Inventory	for	Déjà	vu	Experiences	Assessment	(IDEA)—a	
questionnaire	used	widely	 in	previous	DV	research	(Sno,	Schalken,	
de	 Jonghe,	 &	 Koeter,	 1994)—and	 answered	 “yes”	 to	 the	 question	
A1:”Have	you	ever	had	the	feeling	of	having	experienced	a	sensation	
or	 situation	 before	 in	 exactly	 the	 same	way	when	 in	 fact	 you	 are	
experiencing	it	for	the	first	time?”.
The	DV−	group	included	26	healthy	volunteers	(14M,	12F;	me-
dian	 age	=	24.2	years;	 range	=	20.3	 –	 49.5	years)	with	 no	 personal	
or family history of epilepsy or schizophrenia. These individuals an-
swered	“never”	to	question	A1	of	the	IDEA	questionnaire.
Group factor testing reached statistical significance in the case 
of	 age	 (Kruskal-	Wallis	 test	 H[4,189]	=	59.6,	 p	<	.001)	 and	 gender	
(Pearson	Chi-	square	test,	chi-	square	=	17.9,	p	=	.001).
Written informed consent was obtained from each participant 
after	all	 the	procedures	were	explained	 in	full.	The	study	received	
the approval of the local ethics committee.
2.2 | MRI data acquisition
We	 acquired	 a	 T1	MPRAGE	 high	 resolution	MRI	 for	 each	 subject	
with	 a	 Siemens	 Symphony	 1.5T	 MR	 scanner	 (160	 sagittal	 slices;	
matrix	 size	 256	×	256,	 resampled	 to	 512	×	512;	 TR	=	1,700	ms;	
TE	=	3.96	ms;	 FOV	=	246	mm;	 FA	=	15°;	 slice	 thickness	=	1.17	mm;	
native	in	plane	resolution	=	0.96	mm).	Eight	images	were	discarded	
due to severe motion artifacts identified by visual inspection. The 
resulting images comprised the data described above and analyzed 
as follows.
2.3 | MRI data preprocessing
We	used	the	Freesurfer	6.0	toolbox	for	data	preprocessing	with	ad-
ditional	tool	for	hippocampal	subfields	segmentation	(recon-	all	–all	
–hippocampal-	subfields-	T1	 command)	 (Iglesias	 et	al.,	 2015).	 The	
output of the preprocessing contained an information of the hip-
pocampal	subfields	volumes,	namely	parasubiculum,	presubiculum,	
subiculum,	CA1,	CA3,	CA4,	GC-	DG,	HATA,	fimbria,	molecular	layer	
HP,	 fissure	 and	 tail	 as	well	 as	 an	 estimate	of	 the	 total	 intracranial	
volume	(TIV).	The	subfield	volumes	were	corrected	for	age	and	gen-
der effects using linear regression and for variability in head volume 
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using	normalization	by	TIV.	We	 refer	 to	 these	values	as	 corrected	
subfield	volumes	(CSV).
2.4 | Statistics
The	purpose	of	the	study	was	to	map	GMV	within	distinctive	hip-
pocampal	 subfields,	 and	 to	perform	comparisons	 in	 these	meas-
ures	of	GMV	among	 the	DV+,	DV−,	SCH,	 and	MTLE	groups.	We	
carried	out	two	statistical	tests	with	the	STATISTICA	12	(StatSoft,	
Inc.,	USA).
2.4.1 | Subfield specific GMV decrease
To	 reveal	 subfield	 specific	 GMV	 change	 in	 DV+,	 SCH,	 and	MTLE	
group	relative	to	the	DV−	group,	we	performed	Mann-	Whitney	tests	
on	CSV	for	each	subfield	and	group	(DV+,	SCH	and	MTLE	vs.	DV−).	
The significance level was set to p	<	.05.
2.4.2 | Spatial distribution of GMV decrease
We	computed	median	of	the	CSV	volumes	(mCSV)	across	subjects	
for each group and subfield. To identify which patient group resem-
bles	more	 the	DV+	group	considering	 the	 spatial	 pattern	of	GMV	
deviations	from	DV−	we	further	computed	the	deviation	of	mCSV	
between	DV+/MTLE/SCH	and	DV−	(dmSCV).	The	dmCSV	patterns	
were	 assessed	 using	 Pearson	 correlation	 coefficient,	 that	 is,	 we	
computed	correlation	coefficient	based	on	dmSCV	for	DV+	vs	MTLE	
in	affected	hippocampus	and	DV+	vs	SCH	in	both-	sided	hippocampi.	
The significance level of correlation coefficients was set to p	<	.05.
3  | RESULTS
3.1 | Subfield specific GMV decrease
Significant	GMV	decrease	 in	 the	MTLE	group	 relative	 to	DV−	was	
found	 in	 all	 hippocampal	 subfields	with	 the	 exception	 of	 bilateral	
HATA,	fimbria	and	fissure.	There	was	no	significant	change	of	SCV	
found	in	DV+	or	SCH	groups.	The	extent	and	significance	of	the	de-
crease shows Figure 1.
3.2 | GMV change in Mesial temporal lobe epilepsy
In	the	MTLE	group,	only	the	ipsilateral	hippocampus	was	measured	
regarding the distinctive manner of hippocampal involvement in the 
left	and	right-	sided	MTLE	(Pail	et	al.,	2010).
Significant	GMV	 decrease	 of	 the	MTLE	 group	 relative	 to	DV−	
was	found	in	all	hippocampal	subfields	with	the	exception	of	bilat-
eral	 HATA,	 fimbria	 and	 fissure.	 The	 largest	 relative	 decrease	 was	
F IGURE  1 Relative	gray	matter	volume	(GMV)	decrease	in	DV+,	schizophrenia	(SCH),	and	mesial	temporal	lobe	epilepsy	(MTLE)	
compared	to	DV−	in	distinctive	hippocampal	subfields.	Asterisks	mark	subfields	within	which	GMV	change	reached	statistical	significance	
(p	<	.05)	after	Bonferroni	correction.	The	Y-	axis	indicates	extent	of	GMV	change	relative	to	the	DV−	group
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found	in	the	CA4,	CA3	and	GC-	DG	subfields.	More	specifically,	on	
the	left	side,	the	most	pronounced	decrease	was	measured	in	CA4	
(relative	change	of	volume	in	respect	to	the	volume	of	the	specific	
subfield	 in	 the	DV−	 group	with	 the	 sign	 of	 the	 number	 indicating	
either	decrease	or	increase;	−0.30),	followed	by	CA3	(−0.27)	and	GC-	
DG	 (−0.26)	 subfields.	On	 the	 right	 side	was	 the	greatest	decrease	
found	 in	 the	 CA3	 subfield	 (−0.29),	 then	 CA4	 (−0.27)	 and	 GC-	DG	
(−0.25)	subfields.
3.3 | GMV change in the Déjà vu
There	was	no	 significant	 change	of	GMV	 found	 in	 the	DV+	group	
in	comparison	to	DV−	group	 in	the	present	analysis.	Nevertheless,	
there was a trend showing the most pronounced decrease in the fim-
bria,	CA4,	CA3,	and	fissure	subfields.	On	the	left	side,	the	greatest	
extent	of	the	relative	decrease	was	found	in	the	HATA	(−0.04),	fol-
lowed	by	CA4,	CA3,	and	fissure	(−0.03).	On	the	right	side,	the	largest	
decrease	was	found	in	the	CA3	and	CA4	subfields	(−0.03),	followed	
by	GC-	DG	(−0.02).
In	some	of	the	subfields,	there	was	even	an	insignificant	increase	
in	the	SCV	found—on	the	left	side	it	was	fimbria	(0.04)	and	tail	(0.01).	
On	the	right	side,	it	was	HATA	(0.05)	and	fimbria,	tail	and	subiculum	
(0.01).
3.4 | GMV change in Schizophrenia
There	was	no	significant	change	in	the	GMV	comparing	SCH	vs	DV−	
groups.	Anyway,	the	trend	was	on	the	left	side,	the	greatest	decrease	
was	found	in	HATA	(−0.11),	subiculum	(−0.05),	CA4	and	CA3	(−0.04).
In	 the	 right	 sided	hippocampus,	 the	greatest	extent	of	 the	de-
crease	 was	 found	 in	 the	 presubiculum	 (−0.04),	 CA3	 (−0.03),	 and	
HATA	(−0.02)	subfields.
The	increase	in	the	GMV	was	found	in	the	bilateral	tail	(0.01)	and	
fimbria	(0.02)	and	right	CA1	(0.02)	subfields.
3.5 | Spatial distribution of GMV decrease
To	 assess	 the	 level	 of	 similarity,	we	 compared	 correlation	 coeffi-
cients	based	on	dmCSV	and	computed	for	DV+	vs	SCH	and	DV+	vs	
MTLE.	The	 correlation	 coefficient	 reached	 statistical	 significance	
for	the	left	hippocampus	for	SCH	vs	DV+.	Otherwise	were	the	cor-
relation coefficients without statistical significance. The values of 
the correlation coefficients are listed in Table 1 and the trend of the 
correlation coefficients across subfields is illustrated in Figure 2.
Our	previous	study	(Brázdil	et	al.,	2012)	with	healthy	individuals	
showed	a	morphological	correlate	of	nonpathological	DV	in	terms	of	
GMV	decrease	 throughout	 a	pattern	of	 subcortical	 structures	 en-
compassing	the	hippocampi.	In	these	regions,	GMV	was	correlated	
inversely	with	the	frequency	of	DV	experience.	On	this	basis	we	de-
cided	to	examine	differences	in	GMV	between	the	distinctive	hippo-
campal	subfields	according	to	the	frequency	of	DV	experience	in	the	
DV+	group.	No	statistically	significant	correlation	between	the	GMV	
and	the	frequency	of	the	DV	has	been	found.
4  | DISCUSSION
To	the	best	of	our	knowledge,	this	 is	the	first	study	that	examines	
the	morphological	correlates	of	DV	at	the	level	of	hippocampal	sub-
fields. This level of analysis did not reveal statistically significant 
change	in	GMV	considering	specific	hippocampal	subfields.
On	the	other	hand,	a	significant	change	in	the	GMV	of	distinc-
tive	 hippocampal	 subfields	was	 found	 in	 the	MTLE	 group	 relative	
to	DV−	in	all	hippocampal	subfields	with	the	exception	of	bilateral	
HATA,	fimbria	and	fissure	subfields.	There	was	no	significant	change	
in	hippocampal	GMV	found	in	DV+	or	SCH	groups.
The	expected	change	of	the	GMV	in	conditions	such	as	déjà	vu	
and schizophrenia is subtle considering their nature and in the large 
number of recognized subfields the change is spread finally losing 
statistical	significance.	On	the	other	hand,	expected	decrease	in	the	
case	of	MTLE	with	hippocampal	sclerosis	is	much	more	prominent,	
which may be the cause it was the only difference spotted.
Concerning	the	spatial	distribution	of	GMV	decrease,	we	found	
statistically	significant	correlation	for	the	left	hippocampus	for	SCH	
vs	DV+.	Otherwise	there	was	no	statistically	significant	correlation.	
Thus,	contrary	to	our	hypothesis,	GMV	reductions	 in	healthy	 indi-
viduals	experiencing	DV	resembled	more	closely	the	pattern	of	GMV	
reduction	observed	in	SCH	patients.
Considering	 SCH	group,	 no	 significant	 change	 has	 been	 found	
across hippocampal subfields which corresponds to some histo-
logical	studies	(Walker	et	al.,	2002).	Anyway	the	insignificant	trend	
showing	most	profound	decrease	in	the	HATA,	presubiculum,	subic-
ulum,	CA4	and	CA3	subfields	correspond	to	some	degree	with	the	
recent	 study	of	Haukvik	 et	al.	 (2015)	with	 the	 exception	of	HATA	
subfield,	 which	 was	 not	 recognized	 in	 the	 study.	 Mathew	 et	al.	
(2014),	 however,	 found	 the	most	 prominent	 decrease	 in	CA4-	DG,	
subiculum	and	CA2-	3.	This	discrepancy	could	be	explained	by	 the	
work	 of	 Kühn	 et	al.	 (2012),	who	 report	 a	 negative	 correlation	 be-
tween	 positive	 symptoms	 expression	 and	 the	 volume	 of	 bilateral	
subfields	CA2-	3	and	CA1.	Unfortunately,	Mathew	et	al.	do	not	spec-
ify	the	PANSS	scores	recorded	from	their	subjects,	thus	a	compari-
son	with	our	SCH	group	cannot	be	made.	CA1	sparing	in	the	context	
of	SCH	is	consistent	with	postmortem	studies	(Harrison,	2004).
For	the	MTLE	group,	our	finding	of	GMV	decrease	in	the	majority	
of	the	hippocampal	subfields	is	consistent	with	recent	studies	(Kim,	
Suh,	&	Kim,	2015;	Schoene-	Bake	et	al.,	2014).	The	specific	pattern	of	
GMV	reduction	also	differed	slightly,	as	Kim	et	al.	measured	the	ab-
solute	decrease	and	found	the	most	extensive	reduction	in	ipsilateral	
TABLE  1 The similarities of patterns of gray matter volume 
(GMV)	changes	among	subgroups	based	on	correlation	coefficient
Left hippocampus Right hippocampus
SCH MTLE L SCH MTLE R
DV + .637 (.013) .337	(.142) .135	(.338) .228	(.238)
MTLE,	mesial	temporal	lobe	epilepsy;	SCH,	schizophrenia.
The table shows correlation coefficients and p-	values	 (in	 brackets).	
Statistically	significant	result	marked	bold.
6 of 9  |     PEŠLOVÁ Et aL.
CA2-	3	followed	by	subiculum	and	CA4-	DG.	Our	study	on	the	other	
hand measured relative decrease considering volume of the partic-
ular	subfield	and	found	the	maximal	relative	decrease	 in	 ipsilateral	
CA4	followed	by	CA3	and	GC-	DG.	Sparing	of	the	HATA,	fissure	and	
fimbria subfields has not yet been observed in the literature consid-
ering	the	fact,	that	these	subfields	were	not	recognized.
Hippocampal	sclerosis	present	 in	all	MTLE	subjects	brings	cer-
tain	difficulty	 to	 the	evaluation	of	GMV	decrease,	considering	 the	
ongoing	discussion	whether	it	is	in	fact	a	cause	of	epilepsy,	or	rather	
a	consequence	of	seizure	activity	 itself	 (early	 febrile	seizures,	epi-
sodes	of	status	epilepticus	or	repetitive	brief	seizures;	Thom,	Zhou,	
Martinian,	&	Sisodiya,	2005).	On	the	other	hand,	 the	hippocampal	
sclerosis	 is	 present	 in	 approximately	 70%	 of	 “non-	lesional”	MTLE	
(Cascino	 et	al.,	 1991)	 and	 provides	 certain	 confidence	 to	 MTLE	
diagnostics.
The	 similarity	 of	 nonpathological	DV	 to	 an	 ictal	 event	was	 re-
ported	for	 the	 first	 time	by	Wilder	Penfield	more	than	sixty	years	
ago	(Penfield,	1955).	Such	qualitative	similarity	of	DV	experience	in	
pathological and nonpathological instances was recently confirmed 
(Warren-	Gash	&	Zeman,	2014),	as	were	similarities	in	neuroanatom-
ical	 correlates	 (Brázdil	 et	al.,	 2012)	 suggesting	 a	 common	underly-
ing	process.	Altered	neural	signaling	within	memory-	related	medial	
temporal	brain	structures	resulting	in	changes	in	GMV	in	covariating	
structures is supposed to underlie both pathological and nonpatho-
logical	DV	(Shaw	et	al.,	2015).
Our	primary	expectation	was	therefore	to	find	a	greater	similar-
ity	of	GMV	reduction	pattern	between	the	DV+	and	MTLE	groups	
compared	with	the	DV+	and	SCH	groups.	Ultimately,	however,	our	
results displayed a greater resemblance between the pattern of 
GMV	pattern	in	the	DV+	and	SCH	groups.	We	do	not	consider	such	
resemblance to reflect a direct link between the two conditions. 
Rather,	we	hypothesize	that	this	represents	an	unequal	vulnerability	
of the distinctive subfields to these conditions.
The hippocampus is an especially plastic and vulnerable region of 
the	brain	(McEwen,	1999).	This	vulnerability	was	linked	to	a	variety	
of	insults	including	seizures	(Cavazos,	Das,	&	Sutula,	1994;	Kotloski,	
Lynch,	Lauersdorf,	&	Sutula,	2002;	Mathern	et	al.,	1996;	Tasch	et	al.,	
1999),	 ischemia	(Byeon	et	al.,	2015)	or	 inflammation	(Malaeb	et	al.,	
2014;	 Marsland	 et	al.,	 2015;	 O’Donovan	 et	al.,	 2015),	 as	 well	 as	
gene- environment interactions and physiological influences such 
as	 early	 life	 psychosocial	 stress	 (Butterworth,	 Cherbuin,	 Sachdev,	
&	Anstey,	2012;	Lindauer	et	al.,	2005;	Teicher,	Anderson,	&	Polcari,	
2012;	 Wang	 et	al.,	 2010)	 or	 sleep	 deprivation	 (Novati,	 Hulshof,	
Koolhaas,	Lucassen,	&	Meerlo,	2011).	These	factors,	especially	when	
they	occur	early	in	development,	have	been	linked	to	hippocampal	
atrophy,	alterations	of	postnatal	neurogenesis	and	neuronal	hyper-
excitability	(McEwen,	1999;	Novati	et	al.,	2011).
The mechanism of a deleterious stress action consists of a pro-
longed	glucocorticoid	 (GC)	exposure.	The	actions	of	 these	adrenal	
steroids	occur	predominantly	 in	the	hippocampus,	a	structure	par-
ticularly	rich	in	glucocorticoid	receptors.	This,	in	turn,	leads	to	GC-	
induced	 defense	mechanism	 reduction,	 neuronal	 atrophy,	 or	 even	
neurotoxicity	(Sapolsky,	1996).
Specifically,	 the	 CA3	 subfield	 shows	 an	 abundance	 of	 GC	 re-
ceptors that allow for chronic restraint and psychosocial stress to 
produce	atrophy	of	its	pyramidal	neurons	apical	dendrites	(McEwen,	
F IGURE  2 Scatterplots	representing	the	correlation	in	gray	matter	volume	(GMV)	decrease	relative	to	the	DV−	group	(in	mm3)	between	
the	DV+	and	schizophrenia	(SCH)	or	mesial	temporal	lobe	epilepsy	(MTLE)	groups	in	the	distinctive	hippocampal	subfields	(colour	coded)	
in the left/right sided hippocampus. The x-	axis	value	indicates	GMV	reduction	for	the	DV+	relative	to	DV−	group;	the	y-	axis	indicates	GMV	
reduction	for	SCH	(left)	or	MTLE	group	(right)	relative	to	DV−.	Marks	of	the	left	SCH	group	are	located	at	a	shorter	distance	from	the	line	of	
the	best	fit	relative	to	those	of	the	MTLE	group,	illustrating	the	higher	correlation	between	DV+	and	SCH	compared	to	DV+	and	MTLE	at	the	
left side
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1999)	and	depletion	and	reorganization	of	synaptic	vesicles	in	CA3	
mossy	 fiber	 terminals	 (Magariños,	 Verdugo,	 &	 McEwen,	 1997).	
Chronic elevations in corticosterone have also been shown to 
produce a suppression of synaptic plasticity in the dentate gyrus 
(Pavlides,	Watanabe,	&	McEwen,	1993).	Evidence	of	the	deleterious	
effect	of	stress	exposure	on	selected	subfields	can	be	found	in	the	
case	of	childhood	maltreatment,	where	early	exposure	 to	elevated	
GC	levels	is	believed	to	suppress	neurogenesis	and	advance	to	GMV	
decrease	in	CA3,	CA4,	GC-	DG,	and	subiculum,	respectively	(Teicher	
et	al.,	2012).
Another	condition	indicative	of	a	detrimental	effect	of	excessive	
stress	exposure	is	PTSD.	Sufferers	of	PTSD	have	been	found	to	ex-
press	selective	GMV	loss	in	the	CA3	and	GC-	DG	subfields,	together	
with suppression of neurogenesis and dendritic branching in these 
structures	(Wang	et	al.,	2010).
Considering	our	results	with	most	pronounced	GMV	decrease	in	
corresponding	subfields	in	all	studied	groups	together	with	existing	
findings	of	specific	hippocampal	plasticity	we	hypothesize,	that	var-
ious	adverse	conditions	cause	GMV	decrease	in	specific	increasingly	
vulnerable	subfields	in	the	course	of	neurogenesis.	Déjà	vu,	schizo-
phrenia,	 and	MTLE	 (together	 with	 PTSD	 and	 childhood	 maltreat-
ment)	 then	 represent	 various	 magnitude	 of	 consequent	 aberrant	
functioning depending on the level of hippocampal damage.
Thus,	 we	 conclude	 that	 the	 HATA,	 CA3,	 CA4,	 GC-	DG,	 and	
subiculum subfields of the hippocampus are likely to be more vul-
nerable to adverse conditions. This conclusion is supported by our 
finding	of	the	most	pronounced	GMV	decrease	in	these	particular	
subfields	in	all	studied	groups,	with	the	exception	of	the	right	hip-
pocampus	 in	which	presubicular	GMV	decrease	was	most	promi-
nent for patients with schizophrenia. This assumption converges 
nicely	with	the	studies	of	childhood	maltreatment	and	PTSD	men-
tioned	 above,	with	 the	 exception	of	HATA	which	was	not	 recog-
nized in previous studies.
Certain	 limitations	 of	 our	 study	 demand	 attention.	 Although	
the	resolution	of	raw	MR	images	of	approximately	1	mm	isotropic	
is	considered	as	high	spatial	 resolution	 in	neuroimaging,	still	 it	 is	
some	limitation	of	our	study	as	it	is	quite	near	the	transversal	size	
of	some	parts	of	hippocampus.	Thus,	the	results	might	be	slightly	
biased toward false negative results by the imperfect accuracy 
of	segmentation	process	which	may	occur	in	some	subjects	(Kim,	
Mansi,	Bernasconi,	&	Bernasconi,	2012).	Another	 limitation	con-
sists in comparing clinical groups that differ in terms of “disease” 
duration	and	severity.	Moreover,	considering	its	unpredictable	na-
ture,	the	only	possibility	to	study	déjà	vu	is	in	between	the	events.	
Together	with	the	fact,	that	it	is	a	phenomenon	based	on	the	pa-
tient self- report it brings a certain difficulty in proper assessment 
both	of	the	frequency	and	experience	itself.	Imbalance	in	the	age	
and gender distribution among groups might also potentially bias 
our	 results.	 We	 have,	 however,	 regressed	 the	 potential	 effects	
of	these	nuisance	parameters	out	of	the	data,	a	well-	established	
method	 in	 neuroscience.	 Additionally,	 the	 effects	 of	 lateral-
ity	 and	 medications	 were	 difficult	 to	 interpret	 in	 this	 context.	
There are studies reporting no significant effect of antipsychotic 
medication	 on	 hippocampal	 subfields	 volume	 (Brambilla	 et	al.,	
2013;	Kühn	et	al.,	2012;	Wang	et	al.,	2008;	Zierhut	et	al.,	2013).	
On	the	other	hand,	certain	studies	report	some	level	of	sensitivity	
to	antipsychotic	medication	 in	particular	subfields	 (Mamah	et	al.,	
2012;	Panenka	et	al.,	2007).	Analyses	of	larger	patient	groups	are	
needed in order to provide a detailed characterization of volumet-
ric	 change,	 and	 to	 control	 for	 the	potential	 effects	of	modifying	
factors.	 Future	 studies	 should	 also	 compare	GMV	within	 hippo-
campal	subfields	in	other	disorders,	such	as	depression,	insomnia	
or	Alzheimer’s	disease.
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